IT'S IN OUR NATURE

Serial Number 97422208
602

Registration Progress

Application Filed
May 20, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

IT'S IN OUR NATURE

Basic Information

Serial Number
97422208
Filing Date
May 20, 2022
Abandonment Date
June 2, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 15, 2023
Classes
005

Rights Holder

Biologic Publishing, Inc.

03
Address
688 - 2397 King George Hwy
White Rock V4A7E9
CA

Ownership History

Biologic Publishing, Inc.

Original Applicant
03
White Rock CA

Legal Representation

Attorney
James Surber

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description
Jun 15, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 15, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 15, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 1, 2023 CNFR R FINAL REFUSAL WRITTEN
Mar 1, 2023 GNFR O FINAL REFUSAL E-MAILED
Mar 1, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 13, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 13, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 2, 2022 GNRT F NON-FINAL ACTION E-MAILED
Aug 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2022 DOCK D ASSIGNED TO EXAMINER
May 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Dietary and nutritional supplements for the treatment and prevention of inflammation and inflammatory diseases, arthritis, anxiety, depression, dementia, cancer, fibromyalgia, colitis, Crohn's disease, diverticulitis, gastritis, viral infections, and respiratory diseases; Pharmaceutical preparations for the treatment and prevention of inflammation and inflammatory diseases, arthritis, anxiety, depression, dementia, cancer, fibromyalgia, colitis, Crohn's disease, diverticulitis, gastritis, viral infections, and respiratory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...